2025.7.8
- Statements
- Notices
JSRM explores international collaboration in Integrated Nanobiotechnology to advance regenerative medicine
The Japanese Society for Regenerative Medicine (JSRM; President: Kohji Nishida, based in Chuo-ku, Tokyo) is actively exploring international collaboration opportunities in fields relevant to the advancement of regenerative medicine. As part of these efforts, JSRM has been engaging in dialogue and cooperative initiatives with overseas research institutions working at the intersection of nanotechnology and life sciences.
On April 4, 2025, JSRM signed a Memorandum of Understanding (MoU) with imec, a Belgium-based world-leading research and development center in nanoelectronics and digital technology. A signing ceremony was held on May 19, 2025. The MoU establishes a framework for cooperation in integrated nanobiotechnology, aiming to foster innovation and interdisciplinary collaboration.
This agreement marks aims to bridge the domains of life science and nanoelectronics technology through interdisciplinary and cross-cultural cooperation. The MOU outlines the following key areas of collaboration:
- Formation of joint partnerships for international research and industrialization in nanobiotechnology and regenerative medicine
- Bilateral exchange of scientific, clinical, regulatory, and technological knowledge
- Joint public engagement initiatives to enhance societal understanding of integrated nanobiotechnology
- Other collaborative efforts, including co-hosting of seminars, dispatch of speakers, and support for startups in relevant fields
Statements from Key Stakeholders
Paru Deshpande, Vice-President of imec
“We are pleased with the signing of a Memorandum of Understanding with the JSRM. At imec, we have been working at the intersection of nanoelectronic technology and medical science for many years, and we see that this convergence has greatly accelerated medical science. But as a society, we face many more challenges than one organization can handle, and we see the growing need to build collaborations to develop the next generation of solutions. These collaborations can span technical disciplines, but also societies, countries, and even cultures. At imec we believe that strong collaboration is essential to build a sustainable and healthy future for everyone. So, it’s with great pleasure that we sign this MOU with the JSRM. Japan is a respected leader in the regenerative medicine field and has a strong history of innovation in life sciences, medical devices, and therapeutics. Together we have an opportunity to reinforce our shared belief that collaboration is vital for medical science, vital for society, and vital for wisdom to prevail in a turbulent world.”
Kyosuke Mano, Secretary General of JSRM
“We are delighted to have concluded this MOU with imec, marking the beginning of a promising collaboration between our two organizations. What we mark here is not simply a collaboration between two institutions—but a convergence between life science and nanoelectronics, between biology and computation, between ethics and engineering. Together, we now have the opportunity to build technologies that not only enhance human function, but uplift human values. Our shared mission is clear: To activate this unprecedented intersection—thoughtfully, responsibly, and courageously—to make the world not just more connected or more intelligent, but truly a better place for all.”
About the Japanese Society for Regenerative Medicine (JSRM)
JSRM is one of the largest societies for regenerative medicine globally, with approximately 6,000 members spanning diverse disciplines. Its members engage in a wide array of fields, including basic and clinical medicine, tissue engineering, cell biology, bioethics, regulatory science, law, and medical economics. JSRM serves as a cross-sector platform enabling academia, industry, and government stakeholders to discuss and address emerging challenges in the dynamic field of regenerative medicine.
For more information, please contact:
Foreign Affairs Office
The Japanese Society for Regenerative Medicine
Email: foreignaffairs@jsrm.jp